| PU21.03 | Assessment of crosslinker suitability for fusion peptide conjugates as priming immunogens for an HIV-1 vaccine | Publication Only | Novel vaccine and other prevention approaches |
| PU21.06 | DNA vs ChAd-vectored vaccines as priming vaccines in heterologous prime-boost regimens to increase HTI immunogenicity in mice | Publication Only | Novel vaccine and other prevention approaches |
| PU21.08 | Distinct classes of HIV-1 cross-clade neutralizing antibodies targeting fusion peptide elicited in mice by diverse immunization regimens | Publication Only | Novel vaccine and other prevention approaches |
| PU23.03 | Being a part of the conversation: capacitating youth to participate in HIV prevention conversations using a digital citizen engagement platform in South Africa | Publication Only | Policy and advocacy |
| PU23.04 | Lessons learned from the strategic agenda for key populations: Experiences from Brazil | Publication Only | Policy and advocacy |
| PU24.01 | Birth microbiota in HIV-exposed-uninfected infants cause changes in innate and adaptive immune compartments in a murine model | Publication Only | Preclinical studies for HIV prevention |
| PU25.01 | Social disclosures in relation to perceived HIV protection provided by the dapivirine vaginal ring | Publication Only | Preclinical studies for HIV prevention |
| PU25.02 | Correlates of adherence to the dapivirine vaginal ring for HIV-1 prevention | Publication Only | Product acceptability and adherence |
| PU25.03 | Health care providers' preferences about an MPT implant: insights from South Africa and Zimbabwe on the Subcutaneous Contraceptive HIV Implant Engineered for Long-acting Delivery (SCHIELD) Study | Publication Only | Product acceptability and adherence |
| PU26.01 | Quality and turnaround times of PMTCT viral load monitoring under Option B+ in six South African districts with high antenatal HIV burden | Publication Only | Testing: technology, coverage, viral load, point of care and CD4 count |